and prescription drugs
Professional content for visitors with qualification in medicine or pharmaceuticals This content is only accessible by using your personal password.Learn more
Our products are available in 65 countriesClick here to learn more
Our activities incorporate all areas in the pharmaceutical value chainClick here to learn more
One of the fundamental pillars of our strategy is innovation. We devoted EUR 47 million to research and development in the 2018/2019 financial year.Click here to learn more
The quality of life of millions depends on the availability of our medicines, as Egis sells the most boxes of medicine in Hungary. Hungarian doctors most often choose Egis medicines particularly for the therapy of cardiovascular diseases, which is a common disease. Our medicines provide therapeutic solutions for the diseases cardiovascular diseases (38%), for the illnesses of the central nervous system (17%) and respiratory system (10%), further 10% are cancer treatment and immunotherapeutic drugs. Taking these medicines continuously is essential for maintaining the patients’ quality of life and for the success of the therapy.
The Semmelweis University and Egis Pharmaceuticals PLC have agreed on an even closer cooperation than before. Our common goal is to further raise the standards of pharmaceutical R+D as well as pharmacist and doctor training by making use of the synergies in each other’s activities. As a result of the agreement, new health industrial innovations can be launched and the Semmelweis University can be extended with more practical educational and training elements that also meet the needs of the Hungarian pharmaceutical industry.
To support the CSR activities of local companies, the Hungarian Business Responsibility founded its special awards, called CSR Hungary. This year, Egis was awarded in the ‘Inner CSR Solutions’ category that comes with a two-year trademark right.
Microsoft and HR Fest — the largest HR professional festival in Hungary — established a new professional award category within HR Best awards called ‘Future Proof Organizations’.
One of Egis’ core values is care – with our immediate surroundings as well as in a wider sense. As a responsible company, we strive to support such projects that serve people’s safety and comfort. In this spirit, Egis decided to support the construction of a safe bicycle railroad crossing that is used also by many of our employees daily on their way to our Körmend plant.
Egis’ products are available in 65 countries. Our portfolio consists of 629 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.Learn more about our products